Literature DB >> 1486266

[Surgical correction of astigmatism after perforating keratoplasty].

T Reinhard1, R Sundmacher, H Greber.   

Abstract

Microsurgical control of astigmatism after perforating keratoplasty has widely remained an unsolved problem in spite of many sophisticated suggestions and inventions. The frequent irregularity in the recipient cornea and poor predictability with respect to wound healing are the major obstacles. If spectacles or contact lenses cannot provide useful vision, postoperative surgical correction is needed. Ablative or thermal laser techniques have not been sufficiently tried for such cases to be justified, and one may hesitate anyway to apply destructive methods in transplants. We therefore still use T-incisions and wedge resections, which are said to be rather imprecise. Only 3 out of more than 700 keratoplasties performed in our clinic from 1987 through July 1991 required such procedures. Two more cases were referred by surgeons outside the hospital. All five surgical corrections resulted in a good longterm effect with considerable improvement of vision. Thus, as long as alternative methods for surgical correction of postkeratoplasty astigmatism have not proved to be superior, we should continue to practice these "old" methods, which, indeed, are not bad if properly applied.

Entities:  

Mesh:

Year:  1992        PMID: 1486266

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  3 in total

Review 1.  [Perspectives of femtosecond laser-assisted keratoplasty].

Authors:  F Birnbaum; P Maier; T Reinhard
Journal:  Ophthalmologe       Date:  2011-09       Impact factor: 1.059

2.  [Penetrating keratoplasty with intrastromal corneal ring. A prospective randomized study].

Authors:  F Birnbaum; J Schwartzkopff; D Böhringer; T Reinhard
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059

3.  Clinical results of 123 femtosecond laser-assisted penetrating keratoplasties.

Authors:  Florian Birnbaum; Antonia Wiggermann; Philip C Maier; Daniel Böhringer; Thomas Reinhard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-11       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.